These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26829964)

  • 1. Immune response to PCV2 vaccination in PRRSV viraemic piglets.
    Canelli E; Borghetti P; Ferrari L; De Angelis E; Ferrarini G; Catella A; Ogno G; Martelli P
    Vet Rec; 2016 Feb; 178(8):193. PubMed ID: 26829964
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
    Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
    Park C; Oh Y; Seo HW; Han K; Chae C
    Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
    Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
    Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent vaccination of pigs with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) protects against type 1 PRRSV but not against type 2 PRRSV on dually challenged pigs.
    Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Res Vet Sci; 2015 Dec; 103():193-200. PubMed ID: 26679817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV).
    Shen HG; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
    Vaccine; 2010 Aug; 28(37):5960-6. PubMed ID: 20637768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
    Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
    Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome associations with outcome following co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) in pigs immunized with a PRRS modified live virus vaccine.
    Constance LA; Thissen JB; Jaing CJ; McLoughlin KS; Rowland RRR; Serão NVL; Cino-Ozuna AG; Niederwerder MC
    Vet Microbiol; 2021 Mar; 254():109018. PubMed ID: 33639341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
    Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
    Shi K; Li H; Guo X; Ge X; Jia H; Zheng S; Yang H
    Vet Microbiol; 2008 Jun; 129(3-4):367-77. PubMed ID: 18164875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
    Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
    Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex under Korean field conditions.
    Park C; Seo HW; Han K; Chae C
    Clin Vaccine Immunol; 2014 Mar; 21(3):399-406. PubMed ID: 24403524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses in piglets infected with highly pathogenic porcine reproductive and respiratory syndrome virus.
    Wang G; Song T; Yu Y; Liu Y; Shi W; Wang S; Rong F; Dong J; Liu H; Cai X; Zhou EM
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):170-8. PubMed ID: 21612828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
    Cano JP; Dee SA; Murtaugh MP; Pijoan C
    Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.